Lancet Rheumatology

Article	Citations
Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease	792
Molecular signature-based decision making in the era of targeted therapies for systemic lupus erythematosus	772
COVID-19 vaccine-induced T-cell responses in patients with rheumatoid arthritis: preferential induction by ChAdOx1	278
A disseminated gonococcal infection with spinal locations	186
Thrombotic microangiopathy as a presentation of anti-synthetase syndrome	173
Brachial plexopathy: an unusual manifestation of Takayasu arteritis	147
Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study	133
Research in Brief	133
From phenotype to pathophysiology—placing rheumatic diseases in an immunological perspective	131
Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries	113
Can contextual factors improve clarity of the results from clinical trials of low back pain?	112
Women in rheumatology in Africa	110
Reigniting the burnt-out health-care workforce	99
1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial	90
Dual JAK and ROCK inhibition with CPL'116 in patients with rheumatoid arthritis with inadequate response to methotrexate: a randomised, double-blind, placebo-controlled, phase 2 trial	90
Three-dimensional, in-vitro approaches for modelling soft-tissue joint diseases	87
Pathways driving tendinopathy and enthesitis: siblings or distant cousins in musculoskeletal medicine?	85
Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial	82
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?	81
Biological disease-modification in axial spondyloarthritis: insights from MRI	73
Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands	73
Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica due to lumbar disc herniation	70
Early-stage Dupuytren's disease treatment; a promising next step?	66
Interleukin-5 inhibition in eosinophilic granulomatosis with polyangiitis: time for another approach?	62
Juvenile systemic lupus erythematosus presenting as retinal vasculitis	58

Pausing drugs and spacing vaccines: an open question – Authors' reply	56
Artificial intelligence and high-dimensional technologies in the theragnosis of systemic lupus erythematosus	54
Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology–European League A	53
Pain in clinical trials for knee osteoarthritis: estimation of regression to the mean	52
Preload deficiency as a treatable cause of fatigue and exercise intolerance in SLE	52
Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial	51
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis	49
Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis	45
Composite endpoints for Sjögren's Syndrome	45
Research in Brief	44
Patient-reported outcomes with anifrolumab in patients with systemic lupus erythematosus	44
Reclassifying ANCA-associated vasculitis: a focus on kidney disease	44
Assessing glucocorticoid toxicity: are the measures sensitive enough?	43
Outdoor temperatures and Raynaud's phenomenon in patients with systemic sclerosis	43
Addition of aerobic physical activity to resistance exercise for hip osteoarthritis (PHOENIX): a randomised comparative effectiveness trial	42
Proof-of-concept studies in axial spondyloarthritis: there are no shortcuts	42
Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis	41
Biosimilars and the era of interchangeability	41
The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study	41
First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study	41
Clinical trial design: time to accelerate the pace of change?	40
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study	40
Kanon Jatuworapruk: bringing out the enjoyment in life	39
Let's talk about sex in interstitial lung disease	39
Tackling heterogeneity in Sjögren's disease	38
Mental health before and during the pandemic in people with systemic sclerosis	38
Urgent reform needed for homecare medicines services	37
ANCA-associated large and small vessel vasculitis with aorto-pulmonary-renal syndrome	37
Global access to biological disease-modifying drugs	36
Research in Brief	36
Optimal non-opioid analgesic combinations after total hip arthroplasty – Authors' reply	35
Additional SARS-CoV-2 vaccine doses: a little is better than none	35
Clinical hypnosis and pain management in sharp debridement of skin ulcers in immune-mediated inflammatory diseases	34
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19	34
Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study	33
Constitutional symptoms of severe childhood-onset polyarteritis nodosa	33
Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial	33
Development of a diagnostic prediction model for giant cell arteritis by sequential application of Southend Giant Cell Arteritis Probability Score and ultrasonography: a prospective multicentre study	32
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study	31
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a p	30
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies	30
COVID-19: is the rush to boost backed by science?	29
Who will respond to type I interferon receptor blockade in SLE?	29
Research in Brief	29
Pneumococcal vaccine in adults with immune-mediated inflammatory diseases	28
Sex differences of brain oscillatory activity and quantitative sensory testing in people with chronic osteoarthritis pain: a cross-sectional study	28
Suspending methotrexate for 2 weeks after COVID-19 vaccination	28
Advancing research and equity through collaboration	28
Call for papers: Sex and gender in rheumatology	28
The 2024 US election—voting for equitable health care	27

Are we ready for home spirometry for systemic sclerosis-associated ILD?	27
Humoral response following SARS-CoV-2 vaccination: not all immunosuppressants are created equal	25
Correction to Lancet Rheumatol 2025; published online Feb 27. https://doi.org/10.1016/S2665-9913(24)00348-5	24
Digital self-management for back pain in the UK	24
Better diagnostic tools needed for biopsy-negative giant cell arteritis	24
Explanation for substandard of care comparators in rheumatology randomised trial protocols	24
Intra-articular botulinum toxin A injection for painful base-of-thumb osteoarthritis: a double-blind, randomised, controlled, phase 3 trial (RHIBOT)	24
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort	23
JIA care under the microscope	23
Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level	23
Telemedicine: is the new normal fit for purpose?	23
Cranial involvement in giant cell arteritis	23
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national co	23
Penélope Palominos: rheumatology by sight and touch	22
Polychondritis in a child	22
Reconciling immunotherapy and autoimmunity: not for the faint of heart	22
Pain and wellbeing in young people with arthritis	22
The impact of COVID-19 on care of early inflammatory arthritis in the UK	22
COP27 Climate Change Conference: urgent action needed for Africa and the world	22
Sex and gender impact on achievement of remission in people with rheumatoid arthritis in Switzerland: a cohort study	22
Jean Liew: from Bronte scholar to social media influencer	22
Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials	22
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study	22
Arthritis and fertility: time to think about men	22
Sex-related differences in health-care use in adult patients with inflammatory arthritis in Ontario, Canada: a population-based cohort study	22
Coronary polyarteritis nodosa	21
Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis – Authors' reply	21
For SLE activity and glucocorticoids: aim low	21
Beneficial side-effects of colchicine for patients with gout	21
Microscopic polyangiitis presenting with retinal frosted branch angiitis	20
How long do revised and multiply revised hip replacements last? A retrospective observational study of the National Joint Registry	20
Vascular Ehlers-Danlos syndrome: a heritable condition with potentially fatal consequences	20
Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study	20
Effectiveness of pneumococcal vaccination in adults with common immune-mediated inflammatory diseases in the UK: a case–control study	20
Gout in central Asia: a few things make a big difference	20
Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study	20
Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses	20
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study	20
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial	20
Composite endpoints for Sjögren's Syndrome – Authors' reply	19
Role of plasma exchange in ANCA-associated vasculitis – Authors' reply	19
Thank you to our peer reviewers in 2021	19
Research in Brief	19
DAVIX: a vascular outcome measure in systemic sclerosis	19
A role for interleukin-1 receptor antagonism in severe COVID-19?	19
Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica due to lumbar disc herniation – Authors' reply	19
Effectiveness of a fourth mRNA dose among individuals with systemic autoimmune rheumatic diseases during the Omicron era	18
Research in Brief	18
Rheumatology congresses post COVID-19: we cannot regress	18
David Liew: where communication meets medicine	18
Correction to Lancet Rheumatol 2023; 5: e461–73	18
Ustekinumab with or without methotrexate for psoriatic arthritis?	18
Digital remote monitoring in rheumatology: using health economics to support wider adoption	18
Advancing predictive accuracy for shoulder replacement surgery	17
Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease	17
Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study	17
Coronary polyarteritis nodosa in a young adult	17
Time to revisit the therapeutic benefits of exercise for osteoarthritis?	17
Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbidities	16
Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality among patients who are immunocompromised with COVID-19 in Hong Kong: a retrospective cohort study	16
Substantiation of trophoblast transport of maternal anti-SSA/Ro autoantibodies in fetuses with rapidly progressive cardiac injury: implications for neonatal Fc receptor blockade	16
Titilola (Lola) Falasinnu: looking out for the overlooked	15
Prize trends in rheumatology: the Gender Award Gap	15
Socioeconomic deprivation worsens rheumatoid arthritis	15
Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021	15
Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study	15
Prevention of psoriatic arthritis: the next frontier	15
Occupational therapist-led versus rheumatologist-led care in people with hand osteoarthritis in Norway: an open-label, multicentre, randomised controlled, non-inferiority trial	15
Research in Brief	14
Diffuse alveolar haemorrhage during pregnancy in systemic lupus erythematosus	14
Research in Brief	14
Industry involvement in rheumatology consensus-based recommendations: a systematic review	14
Research in Brief	14
Interosseous tendon inflammation in the hands of patients with clinically suspect arthralgia: analysis of MRI data from a prospective cohort study	14
Susac syndrome: challenges of interpreting treatment data in a rare disease	13
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study	13
Research in Brief	13
Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised contr	13
How should we define disease and outcomes in axial psoriatic arthritis?	13
Palliative care in patients with rheumatic diseases	13

Debate over interventional procedures for chronic spine pain	13
Vasculitis: the promising road ahead	13
Correction to Lancet Rheumatol 2022; 4: e853–63	12
The same genotype gives rise to a spectrum of disorders	12
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine	12
Clinical meaningfulness of a British Isles Lupus Assessment Group-based Composite Lupus Assessment response in terms of patient-reported outcomes in moderate to severe systemic lupus erythematosus: a	12
Cardiovascular risk in gout: time for action	12
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series	12
Correction to Lancet Rheumatol 2022; 4: e177–87	12
Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab	12
Rheumatic cognitive impairment: a new clinical entity?	12
Time to talk to adults with rheumatic diseases about herpes zoster vaccination	12
Predictors of pregnancy outcomes in SLE	11
Preclinical or subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences	11
Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study	11
The influence of safety warnings on the prescribing of JAK inhibitors	11
Michael Barrett: navigating hostile terrain	11
Calcium pyrophosphate deposition disease	11
Promise and challenges of mesenchymal stromal cell therapy in severe SLE	11
Cellular responses to SARS-CoV-2 vaccination after B-cell depletion: conflicting results from studies – Authors' reply	11
Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study	11
Getting better at quantifying the toxicity of glucocorticoids	11
Predictors of pregnancy outcomes in SLE	11
Expanding role of biomarkers in characterising hyperinflammatory syndromes – Authors' reply	11
Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort study	11
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study	11
Identifying key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases: a mixed-methods study	10
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease	10
Aspirin desensitisation in pregnant individuals with autoimmune disease	10
Narendra Kumar Bagri: taking paediatric rheumatology in India to new heights	10
Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study	10
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus – Authors' reply	10
Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis	10
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study	9
Synovial tissue for personalised medicine in rheumatoid arthritis: hype or hope?	9
Contesting the BACPAP consortium's consensus – Authors' reply	9
Research in Brief	9
Challenges of designing and conducting cohort studies and clinical trials in populations of pregnant people	9
Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, obse	9
Correction to Lancet Rheumatol 2022; 4: e262–73	9
Debashish Danda	9
Correction to Lancet Rheumatol 2021; 3: e789–97	9
Moderators of the effect of therapeutic exercise for knee and hip osteoarthritis: a systematic review and individual participant data meta-analysis	9
Kimberly Templeton: creative change maker	9
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial	9
Inclusion of pregnant populations in clinical trials in China: the ethical considerations	9
Research in Brief	9
Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021	9